Trademark: 97418589
Word
UBLIXI
Status Date
Thursday, June 6, 2024
Filing Date
Thursday, May 19, 2022
Published for Opposition
Tuesday, April 11, 2023
5 pharmaceutical preparations and substances for the treatment of oncological, autoimmune and central nervous system diseases and disorders
The wording UBLIXI has no meaning in a foreign language.
May 23, 2022
New Application Entered
May 25, 2022
New Application Office Supplied Data Entered
Mar 8, 2023
Assigned To Examiner
Mar 9, 2023
Approved For Pub - Principal Register
Apr 11, 2023
Published For Opposition
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Jun 6, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 6, 2023
Sou Teas Extension Received
Dec 6, 2023
Sou Extension 1 Filed
Dec 6, 2023
Sou Extension 1 Granted
Jun 6, 2024
Sou Teas Extension Received
Jun 6, 2024
Sou Extension 2 Filed
Jun 6, 2024
Sou Extension 2 Granted
Trademark Alertz updated from USPTO on 2030-01-24